HSBC Life Shield Plan and Rider: The 2026 Guide

Everything you need to know about the new April 2026 rider transitions, premium updates, and how these may affect your coverage.

iFAST Insurance Team
iFAST Insurance Team 23 Apr 2026 3198 Views
HSBC Life Shield Plan and Rider: The 2026 Guide

The April 2026 changes represent a major shift in how health insurance is structured in Singapore. Following the Ministry of Health's (MOH) mandate to ensure long-term sustainability, HSBC Life (along with all other IP providers) has launched new IP riders to encourage "cost discipline."

Here is the breakdown of exactly how these transitions work, what you will pay, and how your hospital bills will change.

Have a shield plan with another insurer? Read our other shield plan updates here:

A Summary of your HSBC Life Shield plan

HSBC Life offers 2 integrated shield plans (IP) that covers for varying ward classes at public and private hospitals, as well as a standard IP. A rider (Enhanced Care or Enhanced Care II) is also offered as an add-on to your shield plan to reduce your out-of-pocket expenses.

Here are the IP plans offered by HSBC Life:

HSBC Life Shield Plan A

HSBC Life Shield Plan B

HSBC Life Shield Standard Plan*

MediShield Life (MSHL)

Ward Entitlement

Private hospital

Class A wards in public hospital

Class B1 wards in public hospital

Class B2/C wards in public hospitals

Annual Limit

Up to $2.5 million for panel specialists or at restructured hospital, or $1 million for non-panel treatments

Up to $1 million

Up to $200,000

Up to $200,000

*This is a no-frills standard integrated shield plan (IP) designed by the government that offers standardised benefits across all IP insurers.

Note: The annual limit for HSBC Life Shield Plan A is $2.5 million when treatment is obtained from panel specialists or at restructured hospital. For non-panel providers, the limit is $1 million for both HSBC Life Shield Plan A and Plan B.

Here is what’s new in April 2026:

🛡️Main Shield plan: HSBC Life Shield plan

1.      Premium Revision

Premiums for HSBC Life Shield Plan A and Plan B has been repriced from 1 April 2026 and affect new purchases and renewals made after 1 April 2026. Premiums will increase between 0 to 35% for HSBC Life Shield Plan A, and between 3 to 15% for HSBC Life Shield Plan B. No changes to premiums are made for the HSBC Life Standard Plan.

Revised premiums for HSBC Life Shield plan:

2.      New risk loading for selected medical conditions

Risk loading will be introduced for HSBC Life Shield policyholders from 1 April 2026. This applies to six medical conditions: Hyperlipidemia, Gastritis, Cataract, Abnormal Urinalysis, Overweight, and Autism, and is available for Plan A, Plan B, and the Standard Plan.

Under this option, clients with specific pre-existing medical conditions can choose to receive coverage for those conditions by paying a higher premium. Alternatively, they may opt to exclude the relevant pre-existing condition instead of accepting the higher premium.

This option is strictly available for new business applications only. Existing policyholders with current exclusions are not eligible to apply for risk loading.

3.      Revision to Pre and Post hospitalisation benefit

Previously, HSBC Life did not differentiate pre- and post-hospitalisation benefits between panel and non-panel specialists. With effect from 1 April 2026, this has changed. To align with industry standards, these benefits will now be separated, with revised coverage limits.

There is no change to benefits for individuals who seek treatment at panel providers or restructured hospitals. However, those who receive treatment from non-panel providers or undergo day surgery procedures will have reduced benefit limits.

Pre and Post Hospitalisation benefit for HSBC Life Shield Plan A and Plan B:

Before 1 April 2026

From 1 April 2026

Pre-Hospitalisation treatment

For Non-Panel specialists or Day surgery

As charged, up to 180 days before hospitalisation

As charged, up to 90 days before hospitalisation

For Panel Specialists or Restructured hospital

As charged, up to 180 days before hospitalisation

Post-Hospitalisation treatment

For Non-Panel specialists or Day surgery

As charged, up to 365 days after hospitalisation

As charged, up to 180 days after hospitalisation

For Panel Specialists or Restructured hospital

As charged, up to 365 days after hospitalisation

4.      First year premium discount

New shield policies purchased from 1 April 2026 will enjoy a 10% first year premium discount. For Public Service Officers + their family members, they get to enjoy additional 10% first year premium discount.

🛡️Rider: HSBC Life Enhanced Care (withdrawn from new businesses from 1 April 2026), and Enhanced Care II Rider

1.      Premium revision

Premiums for HSBC Life Enhanced Care Plan A and Plan B will increase by 29% across all ages. No changes to premiums for Enhanced Care rider attached to Standard plan. Note that Enhanced Care rider is only available for renewals and no longer available for new businesses.

A new HSBC Life Enhanced Care II rider has also been introduced as of 1 April 2026 to replace the old Enhanced Care rider. This new rider will offer 30% cheaper premiums when attached to Plan A, and 35% cheaper premiums when attached to Plan B and Standard plan

Revised premiums for HSBC Life Enhanced Care and Enhanced Care II riders:

2.      Removal of deductible waiver

Under the previous Enhanced Care rider, a $1,500 annual deductible applied to treatment at private non-panel providers. The deductible was waived for treatments at panel specialists and restructured or community hospitals.

With the new Enhanced Care II rider, deductibles will no longer be waived in line with MOH requirements for Integrated Shield Plan riders. Policyholders can expect to pay annual deductibles of up to $3,500 for those aged 80 and below, and up to $5,250 for those aged 81 and above.

3.      Doubled co-insurance cap

Both the previous Enhanced Care rider and the new Enhanced Care II rider require a 5% co-insurance with this amount capped for treatments at Restructured Hospitals or by HSBC Life Panel Specialists. However, under the new Enhanced Care II rider, this co-insurance cap is doubled from $3,000 to $6,000 which may result in higher out-of-pocket costs for larger hospital bills.

4.      Dementia Cover

A new dementia benefit has been introduced for both Enhanced Care and Enhanced Care II riders attached to Plan A and Plan B.

Under this benefit, physician consultation fees and prescribed medication costs (unrelated to inpatient episode) will be reimbursed if the insured is diagnosed with one of the following conditions: Vascular dementia, Alzheimer’s disease, Parkinson’s disease, or Frontotemporal dementia. This benefit provides coverage of up to $500 per policy year and is not subject to deductible or co-insurance.

Commonly asked questions about HSBC Life Shield plan and its riders

Q: What will happen to my existing Enhanced Care rider?

A: If you currently hold the legacy Enhanced Care rider, your coverage remains intact. However, effective 1 April 2026, this rider is no longer available for new applications, upgrades, or downgrades.

How you are affected depends on when you obtained coverage:

  • If you purchased your Enhanced Care rider before 27 November 2025, there are no changes to your rider for now.
  • If you purchased Enhanced Care rider between 27 November 2025 and 31 March 2026, you must transition to the new Enhanced Care II Rider at your first renewal after 1 April 2028.

Q: What are the Value-Added Services (VAS) provided by HSBC Life Shield plans?

A: HSBC Life Shield provides policyholders with a comprehensive suite of Value-Added Services (VAS) to ensure optimal care at reasonable costs. By simply presenting your HSBC Life Shield e-card via the HSBC Life SG application, you can access the following privileges:

  • Preferential Clinic Rates: Access a panel of over 300 General Practitioner (GP) clinics with a flat consultation rate of just $10 per visit.
  • Preferential Specialist Rates: Access an extensive panel of over 800 specialists with standard consultation rates capped at $100 for the first visit and $70 for follow-up visits unless indicated otherwise
  • High Annual Policy and Letter of Guarantee (LOG) Limits: Enjoy exceptionally high Letter of Guarantee (LOG) limits with HSBC Life Shield Plans, reducing the need to make large upfront cash deposits. You may also benefit from annual policy limits of up to $2.5 million under HSBC Life Shield Plan A when receiving treatment from HSBC Life Shield panel doctors.
  • 24/7 HSBC Life Letter of Guarantee (LOG) Hotline: A dedicated 24/7 hotline is available to help you arrange specialist appointments, request a Letter of Guarantee (LOG), or answer claims queries.
  • Tele-medicine: Enjoy preferential consultation rates for tele-medicine services, complete with a waiver of medication delivery charges.

Q: Should I switch from my existing Enhanced Care rider to the new Enhanced Care II rider?

A: Whether you should switch depends on your preference for lower annual premiums versus lower out-of-pocket hospital costs. Here is the trade-off you need to consider:

  • Why you might want to keep your existing Enhanced Care rider: Your existing rider waives the basic plan's hospital deductible and caps your maximum annual out-of-pocket co-insurance at $3,000 (for panel/restructured hospitals). If you switch to the new Enhanced Care II rider, you lose this deductible waiver and must pay the hospital deductible entirely out-of-pocket. Additionally, the new rider doubles your annual co-insurance cap to $6,000.

For individuals age 80 and below

For individuals age 81 and above

(Old) Enhanced Care rider

(New) Enhanced Care II rider

(Old) Enhanced Care rider

(New) Enhanced Care II rider

Annual deductible

$0

Up to $3,500

$0

Up to $5,250

Co-payment cap

$3,000

$6,000

$3,000

$6,000

Maximum out-of-pocket expenses

$3,000

$9,500

$3,000

$11,250

Note: Table shows an illustrated calculation for treatment from a panel specialist at a private hospital. Actual figures may vary depending on the specific IP and IP Rider selected. For illustration purposes only.

  • Why you might want to switch to Enhanced Care II: Because of the stricter cost-sharing limits, the new Enhanced Care II rider offers significantly cheaper annual premiums compared to the revised renewal premiums of the legacy Enhanced Care rider. Moving to the new rider may help you manage your long-term premium affordability.

Note that if you plan to upgrade or downgrade your base HSBC Life Shield plan tier (e.g. from Plan A to Plan B), you will not be allowed to keep your legacy Enhanced Care rider and will be forced to transition to the new Enhanced Care II rider upon making the change.

Unlock Rewards when you review, upgrade, or downgrade your Shield plan

Why settle for just a review when you can get rewarded? From now till 30 June 2026, give your Shield Plan the check-up it deserves and unlock:

  • Up to $50 Cash Reward* 💵
  • Up to 45% Commission Rebates^ on eligible plans
  • Expert Guidance (Even if you don't have an agent!)

No agent? No problem. Let us be your agent and snag an extra $5 Reward* just for making the transfer. Transfer-in reward applicable for Income and Raffles Shield plans only.

👉🏻 Click here to get started.

*Terms and conditions can be found here.

Unsure about what to do with your HSBC Life Shield plan?

Click here to schedule a complimentary review

You may also be interested in:

Available Products on FSMOne Insurance

Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)

from AIA, AIG, Allianz, China Taiping, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE.

*Please check with our team if the product you want is available on FSMOne Insurance

Information obtained from:
https://www.insurance.hsbc.com.sg/content/dam/hsbc/insn/documents/health/hsbc-new-rider-drawer-statement-and-faq.pdf
https://www.insurance.hsbc.com.sg/health/products/shield
https://www.insurance.hsbc.com.sg/content/dam/hsbc/insn/documents/health/telemedicine-faqs.pdf
https://www.insurance.hsbc.com.sg/health/products/shield/panel-and-letter-of-guarantee/
Information retrieved on 16 April 2026.

Disclaimer:
^More information on our commission rebate program can be found here.
The views and opinions expressed in this article are solely our own and do not represent those of the insurer.
All materials and content found in this advertisement are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product. This advertisement is not a contract of insurance.
Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to review the specific terms, conditions and exclusions in the relevant policy contract.
You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.
While iFAST and its third-party providers strive to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.
The comparisons and opinions provided are based on publicly available data/information and are intended to provide a general overview of the insurance products discussed. These comparisons do not cover all available products and may not fully illustrate every aspect of the products discussed.
Purchasing a life insurance policy is a long-term commitment, and early termination may involve significant costs. The surrender value, if any, may be zero or less than the total premiums paid.
This advertisement has not been reviewed by the Monetary Authority of Singapore.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.